Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2003
11/04/2003US6641571 Reduction of postoperative complications of cardiopulmonary bypass (CPB) surgery
11/04/2003CA2290709C 2,6-diaminopyridine compounds as intermediates for producing antibacterial dihydropyridone carboxylic acid derivatives
11/04/2003CA2257322C Thiazole derivatives
11/04/2003CA2232728C Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
11/04/2003CA2188283C Substituted 1,3-oxathiolanes with antiviral properties
11/04/2003CA2085191C Vaccines based on modified type 1 bovine herpesviruses
11/04/2003CA2071811C Improved meningococcal polysaccharide conjugate vaccine
11/03/2003CA2427574A1 Plant bioreactor
10/2003
10/31/2003CA2444598A1 Compositions useful as inhibitors of gsk-3
10/30/2003WO2003089934A2 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1/lap-1
10/30/2003WO2003089933A1 Uses of the carbamoyl phosphate synthesis 1 (cps 1) and the fragments thereof for the diagnosis of inflammatory diseases and sepsis
10/30/2003WO2003089903A2 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1)
10/30/2003WO2003089615A2 Antiviral inhibitions of capsid proteins
10/30/2003WO2003089607A2 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them
10/30/2003WO2003089593A2 Adjuvant enhanced immunotherapy
10/30/2003WO2003089573A2 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/30/2003WO2003089571A2 Ehrlichia canis genes and vaccines
10/30/2003WO2003089472A2 Anti-nls scfv and peptides and uses thereof in nuclear import inhibition
10/30/2003WO2003089462A2 Tuberculosis vaccines including recombinant bcg strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase
10/30/2003WO2003089450A2 Fusion polypeptides and methods for inhibiting microbial adhesion
10/30/2003WO2003089448A1 Ibuprofen ribavirin ester, its method of preparation and use
10/30/2003WO2003089447A1 5-o-mycaminosyltylonide derivatives
10/30/2003WO2003089446A2 23-o-substituted 5-o-mycaminosyltylonide derivatives
10/30/2003WO2003089434A2 IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF
10/30/2003WO2003089431A1 Novel carbapenem compounds
10/30/2003WO2003089421A1 Antiviral lactone-ureas
10/30/2003WO2003089412A1 Antibacterial agents
10/30/2003WO2003089405A1 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition
10/30/2003WO2003089010A1 Glycodendrimers having biological activity
10/30/2003WO2003089006A1 Combination of an agent that attenuates topoisomerase 1 activity and an agent that inhibits heat shock protein 90 for use in chemotherapy
10/30/2003WO2003089004A1 Preventives for hiv infection
10/30/2003WO2003089003A1 Methods of treatment and diagnosis of patients with hepatitis c infection
10/30/2003WO2003089000A2 Anti-hiv composition, production method thereof and medicament
10/30/2003WO2003088999A1 Process for producing immunogloblin preparation
10/30/2003WO2003088995A2 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/30/2003WO2003088994A2 Modified vaccinia virus ankara for the vaccination of neonates
10/30/2003WO2003088983A1 Use of topical compositions for the control of microbial diseases of the nail
10/30/2003WO2003088981A1 Methods of treating necrotizing enterocolitis
10/30/2003WO2003088972A1 Novel compounds
10/30/2003WO2003088965A1 Use of materials having zinc ionophoric behavior
10/30/2003WO2003088957A1 Personal care compositions comprising a zinc containing material in an aqueous surfactant composition
10/30/2003WO2003088927A2 Novel curcumin analogues and uses thereof
10/30/2003WO2003088903A2 Compounds, compositions, and methods
10/30/2003WO2003088748A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003WO2003063796A3 Heterocyclic arylsulfonamidobenzylic compounds
10/30/2003WO2003063725A3 Methods of preventing and treating flavivirus infection in animals
10/30/2003WO2003059334A3 Gemcitabine in the treatment of smallpox
10/30/2003WO2003052095A3 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell
10/30/2003WO2003051277A3 Novel compounds
10/30/2003WO2003051274A3 Benzodiazepine derivatives, preparation thereof and use thereof
10/30/2003WO2003045319A3 Targeted therapeutics and uses thereof
10/30/2003WO2003038032A3 Means for inhibition of the synthesis of viral proteins
10/30/2003WO2003037370A3 Anthrax antigenic compositions
10/30/2003WO2003034903A3 Psma antibodies and protein multimers
10/30/2003WO2003031588A3 Hepatitis c virus vaccine
10/30/2003WO2003025199A3 Mid 4460, a human tyrosine phosphatase family member and uses therefor
10/30/2003WO2003024480A3 In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
10/30/2003WO2003024455A3 Stent coated with a sustained-release drug delivery and method for use thereof
10/30/2003WO2003020309A3 Compound
10/30/2003WO2003018619A3 Antimicrobial and anti-inflammatory peptides
10/30/2003WO2003016549A3 Nucleic-acid associated proteins
10/30/2003WO2003000877A3 A soluble complex comprising a retroviral surface glycoprotein
10/30/2003WO2002097030A3 Peptides derived from neural thread proteins and their medical use
10/30/2003WO2002093519A3 Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus
10/30/2003WO2002084294A3 Gastrointestinal glutathione peroxidase in hepatitis c virus infections
10/30/2003WO2002079247A3 Intimins in the prevention or treatment of infections:ii
10/30/2003WO2002070547A8 Template-fixed peptidomimetics with antimicrobial activity
10/30/2003WO2002066476A9 6-phenylbenzonaphthyridines
10/30/2003WO2002064162A3 Vaccine for transcutaneous immunization
10/30/2003WO2002056916A3 Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients
10/30/2003WO2002056909A3 Method for inducing an immune response to polysaccharide bacterial antigens and to protein structures of virus capsids
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003WO2002032447A3 Cell damage inhibitor
10/30/2003WO2002007742A8 Bacteriophage having multiple host range
10/30/2003WO2001057071A3 Glycopeptide derivatives having antibiotic activity
10/30/2003US20030204097 For inhibiting retroviral proteases, such as human immunodeficiency virus (HIV) protease
10/30/2003US20030204086 Novel heterocyclic amide derivatives
10/30/2003US20030204082 To an aqueous solution of cefdinir an organic solvent is added in a percentage v/v up to 10%, the solution is cooled to a temperature 0-6 degree C. in acedic pH, to enhance precipitation of cefdinir new crystals
10/30/2003US20030204074 Streptococcus pneumoniae 37-kDa surface adhesin a protein
10/30/2003US20030203974 Topical administration of dihydroxytoluene to block viral replication
10/30/2003US20030203969 Pharmaceutically active aromatic guanylhydrazones
10/30/2003US20030203962 Purified plant proanthocyanidin extract, capable of inhibiting agglutination of P-type Escherichia coli and not capable of inhibiting agglutination of type 1 Escherichia coli; proanthocyanidin having 4-12 epicatechin flavanoid units
10/30/2003US20030203957 Selected fused pyrrolocarbazoles
10/30/2003US20030203951 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
10/30/2003US20030203948 Compounds having anti-hepatitics c virus effect
10/30/2003US20030203933 Novel curcumin analogues and uses thereof
10/30/2003US20030203926 For treatment of inflammatory or autoimmune condition, viral infection, cancer
10/30/2003US20030203924 Combination for treating susceptible tumor comprising (S)-2-(5-(((1,2-dihydro-3-methyl-1-oxobenzo(f) quinazolin-9-yl)methyl)amino)-1-oxo-2-isoindolinyl)glutaric acid and folic acid
10/30/2003US20030203922 Substituted amine derivatives and methods of use
10/30/2003US20030203910 A phenoxy-alkyl-quinoxalinone derivatives for inhibiting drug transport proteins that efflux therapeutic agents from cells; synergistic
10/30/2003US20030203905 Inhibitors of p38
10/30/2003US20030203903 Administering a rifamycin microbiocides for treating infections caused by Mycobacterium tuberculosis, Mycobacterium avium complex, Chlamydia pneumoniae or Helicobacter pylori
10/30/2003US20030203893 Benzimidazole derivatives, preparation and therapeutic use thereof
10/30/2003US20030203886 Process for the production of clavulanic acid salts
10/30/2003US20030203870 Method and reagent for the inhibition of NOGO and NOGO receptor genes
10/30/2003US20030203858 5-O-mycaminosyltylonide derivatives
10/30/2003US20030203855 17-Aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
10/30/2003US20030203852 Acyl pseudodipeptides which carry a functionalised auxialiary arm
10/30/2003US20030203848 Peptaibol antibiotics, synthesized from Acremonium tubakii, during fermentation and released into culture medium, containing high content of beta-aminobutyric acid and isovaline
10/30/2003US20030203472 Episome for transfer and expression of heterologous nucleotide sequences in gram positive bacteria; genetic vaccines
1 ... 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 ... 1798